Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rajeev Pakhetra"'
Autor:
Abhay Gundgurthi, M K Garg, Velu Nair, Rajeev Pakhetra, Satyanarayan Das, Sanjeevan Sharma, Manoj K Dutta, Sandeep Kharb, Rajan Kapoor
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 5, Pp 855-863 (2013)
Introduction: Endocrine complications are common after hematopoietic stem cell transplant (HSCT). Although HSCT is performed at various centers in India, no study is available for endocrine dysfunctions among them. This study was carried out with the
Externí odkaz:
https://doaj.org/article/e8eba1e6a8b54573b2707199e87f21d5
Autor:
Rajeev Pakhetra, Anup Halappanavar
Publikováno v:
Clin Med (Lond)
Ageing, obesity and chronic illness are major factors affecting serum testosterone (T) levels in men. The magnitude of the impact of ageing on serum T levels is well established; for obesity this is less clear.[1–4][1] Severe obesity may lead to is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a7588faff3979b5c7f1a8a9ee4c8a92
https://pubmed.ncbi.nlm.nih.gov/32409412
https://pubmed.ncbi.nlm.nih.gov/32409412
Autor:
Anup Halappanavar, Rajeev Pakhetra
Publikováno v:
Clinical Medicine. 19:7-8
Insulinoma is a rare pancreatic endocrine tumour derived from s cells that secrete insulin, which results in recurrent hypoglycaemia. Most are benign and solitary. The age range for peak incidence is between 30 and 60 years (median 47 years) and it i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::750a9d2ec13ef576467bc164e14f3d29
https://doi.org/10.7861/clinmedicine.19-3-s7
https://doi.org/10.7861/clinmedicine.19-3-s7
Autor:
Rajan Kapoor, Sandeep Kharb, Satyanarayan Das, MK Dutta, Rajeev Pakhetra, Abhay Gundgurthi, Sanjeevan Sharma, MK Garg, Velu Nair
Publikováno v:
Indian Journal of Endocrinology and Metabolism
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 5, Pp 855-863 (2013)
Indian Journal of Endocrinology and Metabolism, Vol 17, Iss 5, Pp 855-863 (2013)
Introduction: Endocrine complications are common after hematopoietic stem cell transplant (HSCT). Although HSCT is performed at various centers in India, no study is available for endocrine dysfunctions among them. This study was carried out with the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c955a8ceb61a6d8a6da3af787a15b47
https://pubmed.ncbi.nlm.nih.gov/24083167
https://pubmed.ncbi.nlm.nih.gov/24083167
Autor:
Halappanavar, Anup1 (AUTHOR), Pakhetra, Rajeev2 (AUTHOR)
Publikováno v:
Clinical Medicine. 2019 Supplement, Vol. 19, ps7-s8. 2p.
Publikováno v:
Clinical Medicine. 2019 Supplement, Vol. 19, ps1-s94. 94p.
Autor:
Gundgurthi, Abhay1, Garg, M. K.1 mkgargs@gmail.com, Nair, Velu2, Pakhetra, Rajeev1, Das, Satyanarayan2, Sharma, Sanjeevan1, Dutta, Manoj K.1, Kharb, Sandeep1, Kapoor, Rajan2
Publikováno v:
Indian Journal of Endocrinology & Metabolism. Sep/Oct2013, Vol. 17 Issue 5, p855-863. 9p.